Candice D. Church

Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · Journal of Clinical Oncology · 2019 · 390 citations · Full text

Medicine, Oncology, Pharmacology +17

Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA

Kelly G. Paulson, Valentin Voillet, Megan S. McAfee et al. · Nature Communications · 2018 · 287 citations · Full text

Life Sciences, Immunology, Oncology +17

Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab

Nicolás A. Giraldo, Peter Nguyen, Elizabeth L. Engle et al. · Journal for ImmunoTherapy of Cancer · 2018 · 183 citations · Full text

Medicine, Oncology, Pathology +17

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · Journal for ImmunoTherapy of Cancer · 2021 · 140 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide–MHC complexes

Amalie Kai Bentzen, Lina Such, Kamilla Kjærgaard Jensen et al. · Nature Biotechnology · 2018 · 96 citations · Full text

Life Sciences, Immunology, Molecular Biology +16